Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Baxter Healthcare is recalling 63,360 bags of Potassium Chloride Injection due to incorrect outer packaging labels indicating a higher strength.
Actavis Laboratories is recalling 5,451 bottles of Diclofenac Sodium and Misoprostol tablets because some contain split or broken tablets.
Zydus Pharmaceuticals is recalling Amlodipine Besylate 10 mg tablets due to brown spots embedded in the product.
Abrams Royal Pharmacy is recalling Trace Mineral-5 MDV vials because a contract laboratory identified Staphylococcus warneri in the product, indicating non-sterility.
Abrams Royal Pharmacy is recalling 50 syringes of a compounded lidocaine and bupivacaine mixture due to non-sterility. The products were distributed in Texas.
Abrams Royal Pharmacy is recalling 1,100 vials of Calcium Chloride Preservative Free Sterile Injection because contract testing found sterility failures.
Micro Labs USA is recalling 1,440 bottles of Losartan Potassium 25 mg tablets because the dry mix failed blend uniformity specifications.
Spectrum Laboratory Products is recalling 16 bottles of Tetrahydrozoline Hydrochloride, USP, 1 KG Bottle, due to storage in a non-GMP compliant warehouse.
Prometheus Laboratories is recalling Mercaptopurine Tablets 50mg because the product failed dissolution specifications during stability testing.
Hospira Inc. is recalling 316,640 vials of Vancomycin Hydrochloride for Injection because product trays were mislabeled to contain a different product.
Fougera Pharmaceuticals is recalling specific lots of Fluocinonide Gel USP, 0.05% because they may not meet USP requirements for residual solvents.
Contract Packaging Resources Inc. is recalling Assured Naproxen Sodium Tablets because correct labeled bottles of Assured Ibuprofen softgels were mistakenly packaged into Naproxen cartons.
Micro Labs USA Inc. is recalling 1,008 bottles of Simvastatin Tablets, 10 mg, because the product failed impurity content specifications.
Fresenius Kabi is recalling Haloperidol Decanoate Injection vials due to an out-of-specification impurity result. The recall covers 216,517 vials distributed nationwide and in Puerto Rico.
Oregon Compounding Centers is recalling specific lots of Calcium Chloride Injectable due to quality control issues affecting sterility assurance identified during an FDA inspection.
Oregon Compounding Centers is recalling Gentamicin Sulfate irrigation solution due to quality control issues affecting sterility assurance identified during an FDA inspection.
Oregon Compounding Centers is recalling hyaluronidase injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.
Oregon Compounding Centers is recalling compounded Testosterone Cypionate injectable vials due to quality control issues affecting sterility assurance.
Oregon Compounding Centers is recalling specific lots of a compounded injectable drug due to quality control issues affecting sterility assurance.
Creative Compounds is recalling Gentamicin Sulfate irrigation solution due to quality control issues affecting sterility assurance identified during an FDA inspection.
Oregon Compounding Centers is recalling Procaine HCL injectable vials due to quality control issues affecting sterility assurance.
Oregon Compounding Centers is recalling specific lots of a sterile injectable drug due to quality control issues that may compromise sterility.
Oregon Compounding Centers is recalling injectable Ascorbic Acid (Vitamin B) due to quality control issues affecting sterility assurance identified during an FDA inspection.
Oregon Compounding Centers is recalling Renacidin solution due to quality control issues affecting sterility assurance identified during an FDA inspection.
Oregon Compounding Centers is recalling Papaverine/Phentolamine/Prostaglandin injectable vials due to quality control issues affecting sterility assurance.